MA42685A - Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation - Google Patents
Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisationInfo
- Publication number
- MA42685A MA42685A MA042685A MA42685A MA42685A MA 42685 A MA42685 A MA 42685A MA 042685 A MA042685 A MA 042685A MA 42685 A MA42685 A MA 42685A MA 42685 A MA42685 A MA 42685A
- Authority
- MA
- Morocco
- Prior art keywords
- hydrochloride
- dextromethadone
- synthesis
- methods
- levomethadone
- Prior art date
Links
- FJQXCDYVZAHXNS-LMOVPXPDSA-N (6s)-6-(dimethylamino)-4,4-diphenylheptan-3-one;hydrochloride Chemical compound Cl.C=1C=CC=CC=1C(C[C@H](C)N(C)C)(C(=O)CC)C1=CC=CC=C1 FJQXCDYVZAHXNS-LMOVPXPDSA-N 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 229960002710 levomethadone Drugs 0.000 title 1
- USSIQXCVUWKGNF-QGZVFWFLSA-N levomethadone Chemical compound C=1C=CC=CC=1C(C[C@@H](C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-QGZVFWFLSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/02—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
- C07C225/14—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
- C07C225/16—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C253/00—Preparation of carboxylic acid nitriles
- C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562209168P | 2015-08-24 | 2015-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42685A true MA42685A (fr) | 2018-07-04 |
Family
ID=56853854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA042685A MA42685A (fr) | 2015-08-24 | 2016-08-24 | Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10040752B2 (fr) |
| EP (1) | EP3341354A1 (fr) |
| CN (1) | CN108137483A (fr) |
| MA (1) | MA42685A (fr) |
| WO (1) | WO2017035224A1 (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10040752B2 (en) * | 2015-08-24 | 2018-08-07 | Cody Laboratories, Inc. | Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof |
| AU2018215056A1 (en) * | 2017-01-31 | 2019-08-08 | Charles E. Inturrisi | D-methadone and its derivatives for use in the treatment of disorders of the nervous system |
| CN108693272B (zh) * | 2018-06-04 | 2021-03-12 | 吉林百纯化学科技有限公司 | 一种hplc法分析及制备n-（对甲苯磺酰基）-l-丙氨酸及其对映异构体的方法 |
| US20200033307A1 (en) * | 2018-07-25 | 2020-01-30 | Honeywell International Inc. | Method of determining an amount of water in a sample using a derivative of imidazole and a hydrogen halide donor |
| US11332434B2 (en) * | 2019-04-17 | 2022-05-17 | Javad Safaei-Ghomi | Synthesis of levomethadone hydrochloride |
| CN110818908B (zh) * | 2019-08-29 | 2021-12-17 | 杭州市富阳区浙工大银湖创新创业研究院 | 一种用于检测氧化气体的金属有机骨架材料的制备方法 |
| MX2023011966A (es) | 2021-04-09 | 2024-01-08 | Paolo L Manfredi | Novedosos métodos para sintetizar (s)-metadona enantiopura, (r)-metadona enantiopura, (r,s)-metadona racémica y sustancias análogas relacionadas. |
| CN117999071A (zh) * | 2021-06-30 | 2024-05-07 | 保罗·L·曼佛雷蒂 | 美沙酮及其异构体、艾美沙酮和左美沙酮及衍生物的调释配制品 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2540636A (en) | 1947-11-12 | 1951-02-06 | Mallinckrodt Chemical Works | Separation of nitrile intermediates in amidone synthesis |
| US2497739A (en) | 1949-01-05 | 1950-02-14 | Merck & Co Inc | Process of separating isomers of amidone intermediates |
| US2601323A (en) | 1949-02-02 | 1952-06-24 | Upjohn Co | Process for preparing 4, 4-diphenyl-6-dimethylamino-heptanone-3 |
| GB1124682A (en) | 1966-06-21 | 1968-08-21 | Wyeth John & Brother Ltd | Preparation of amines |
| US4048211A (en) | 1976-05-10 | 1977-09-13 | Eli Lilly And Company | Modification of methadone synthesis process step |
| US4242274A (en) | 1979-06-18 | 1980-12-30 | Mallinckrodt, Inc. | Process for the preparation of 2,2-diphenyl-4-(dimethylamino)-pentane nitrile |
| GB9611041D0 (en) | 1996-05-25 | 1996-07-31 | Salford Ultrafine Chem & Res | Process for the preparation of optically active methadones in high enantiomeric purity |
| SK287446B6 (sk) | 2007-02-08 | 2010-10-07 | Zentiva, A. S. | Spôsob prípravy metadóniumchloridu |
| CA2837312A1 (fr) | 2011-05-26 | 2012-11-29 | Sunovion Pharmaceuticals Inc. | Modulateurs allosteriques du recepteur 5 du glutamate methabotropique et methodes d'utilisation associees |
| MY183354A (en) | 2011-11-22 | 2021-02-18 | Univ Sains Malaysia | (r)-6-(dimthylamino)-4,4-diphenylheptan-3-one |
| US9468611B2 (en) | 2012-09-27 | 2016-10-18 | Relmada Therapeutics, Inc. | d-Methadone for the treatment of psychiatric symptoms |
| US10040752B2 (en) * | 2015-08-24 | 2018-08-07 | Cody Laboratories, Inc. | Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof |
-
2016
- 2016-08-24 US US15/245,935 patent/US10040752B2/en active Active
- 2016-08-24 CN CN201680061096.XA patent/CN108137483A/zh active Pending
- 2016-08-24 MA MA042685A patent/MA42685A/fr unknown
- 2016-08-24 EP EP16760285.3A patent/EP3341354A1/fr not_active Withdrawn
- 2016-08-24 WO PCT/US2016/048380 patent/WO2017035224A1/fr not_active Ceased
-
2018
- 2018-06-29 US US16/024,283 patent/US20190002394A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170057909A1 (en) | 2017-03-02 |
| EP3341354A1 (fr) | 2018-07-04 |
| US10040752B2 (en) | 2018-08-07 |
| WO2017035224A1 (fr) | 2017-03-02 |
| CN108137483A (zh) | 2018-06-08 |
| US20190002394A1 (en) | 2019-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3700527A4 (fr) | Inhibiteurs de papd5 et leurs méthodes d'utilisation | |
| EP3383430A4 (fr) | Anticorps et leurs méthodes d'utilisation | |
| EP3319611A4 (fr) | Oxystérols et leurs méthodes d'utilisation | |
| MA44955A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
| EP3337517A4 (fr) | Conjugués anticorps-médicaments anti-dll3 et méthodes d'utilisation | |
| MA46481A (fr) | Compositions d'oligonucléotides et méthodes associées | |
| MA45123A (fr) | Anticorps anti-tim-3 et leurs méthodes d'utilisation | |
| MA48595A (fr) | Anticorps anti-tau et leurs méthodes d'utilisation | |
| EP3383431A4 (fr) | Anticorps anti-gitr et leurs méthodes d'utilisation | |
| EP3436048A4 (fr) | Néoantigènes et leurs procédés d'utilisation | |
| MA44526A (fr) | Oxystérols et leurs méthodes d'utilisation | |
| EP3402549A4 (fr) | Compositions pour micro-aiguilles et méthodes d'utilisation de celles-ci | |
| MA42302A (fr) | Lactames bicycliques et leurs méthodes d'utilisation | |
| MA42925A (fr) | Anticorps anti-tigit et méthodes d'utilisation | |
| EP3390624A4 (fr) | Polypeptides de modification ciblée modifiés et leurs procédés d'utilisation | |
| EP3356381A4 (fr) | Dérivés nucléotidiques et leurs méthodes d'utilisation | |
| MA42685A (fr) | Synthèse de chlorhydrate de lévométhadone ou de chlorhydrate de dextrométhadone et leurs méthodes d'utilisation | |
| EP3525583A4 (fr) | Anticorps anti-c1s et leurs méthodes d'utilisation | |
| EP3435956A4 (fr) | Compositions photo-stabilisées et leurs procédés d'utilisation | |
| EP3319610A4 (fr) | Oxystérols et leurs procédés d'utilisation | |
| EP3319612A4 (fr) | Oxystérols et leurs procédés d'utilisation | |
| EP3419656A4 (fr) | Compositions de néoantigène et leurs méthodes d'utilisation en immuno-oncothérapie | |
| EP3341218C0 (fr) | Compositions de moulage et leurs méthodes d'utilisation | |
| MA46422A (fr) | Oligonucléotides modifiés et méthodes d'utilisation | |
| MA42118A (fr) | Benzamides substitués et leurs méthodes d'utilisation |